This wiki has undergone a migration to Confluence found Here
Difference between revisions of "2016-06-01 SGB Conference Call"
Jump to navigation
Jump to search
(Created page with "{{subst:: SGB Template}}") |
|||
Line 12: | Line 12: | ||
| colspan="2" align="left" style="background:#f0f0f0;"|'''HL7 SGB Minutes''' <br/> | | colspan="2" align="left" style="background:#f0f0f0;"|'''HL7 SGB Minutes''' <br/> | ||
'''Location: ''' <br/>https://global.gotomeeting.com/join/538465637 | '''Location: ''' <br/>https://global.gotomeeting.com/join/538465637 | ||
− | | colspan="2" align="left" style="background:#f0f0f0;"|'''Date: 2016- | + | | colspan="2" align="left" style="background:#f0f0f0;"|'''Date: 2016-06-01'''<br/> '''Time: 10:00 AM Eastern''' |
|- | |- | ||
| colspan="1" align="right"|'''Facilitator''' | | colspan="1" align="right"|'''Facilitator''' | ||
Line 74: | Line 74: | ||
===Agenda=== | ===Agenda=== | ||
*Agenda review | *Agenda review | ||
+ | *Review minutes of [[2016-05-25_SGB_Conference_Call]] | ||
+ | *Homework | ||
+ | **Forward risks to the group for consideration | ||
+ | *Action Items | ||
+ | **Lorraine to send risk and precept material that Ron put together to the group | ||
*Discussion Topics | *Discussion Topics | ||
+ | **HTA Followup Discussion | ||
+ | **Risk assessment | ||
+ | **Defining the role of product director - joint with ARB | ||
+ | ***Need to invite Grahame to discuss | ||
+ | **CDA Product Family Formation | ||
+ | **Further discussion on SGB Guidance on IG Conformance Statements (from [http://hl7tsc.org/wiki/index.php?title=2016-02-22_TSC_Call_Agenda 2016-02-22 TSC Call]) | ||
+ | **Role of Steering Divisions | ||
+ | **FHIR Governance Board | ||
+ | **Balloting standards which are cross-product family | ||
===Minutes=== | ===Minutes=== | ||
Line 108: | Line 122: | ||
|width="100%" |'''Next Meeting/Preliminary Agenda Items'''<br/> | |width="100%" |'''Next Meeting/Preliminary Agenda Items'''<br/> | ||
− | *[[ | + | *[[20160608 SGB Conference Call]] |
|} | |} | ||
© 2016 Health Level Seven® International. All rights reserved | © 2016 Health Level Seven® International. All rights reserved |
Revision as of 21:21, 31 May 2016
back to Standards Governance Board main page
HL7 SGB Minutes |
Date: 2016-06-01 Time: 10:00 AM Eastern | ||
Facilitator | Paul/Calvin | Note taker(s) | Anne |
Attendee | Name
| ||
Calvin Beebe | |||
Lorraine Constable | |||
Russ Hamm | |||
Tony Julian | |||
Paul Knapp | |||
Austin Kreisler | |||
Wayne Kubick | |||
Mary Kay McDaniel | |||
Ken McCaslin | |||
Rik Smithies | |||
no quorum definition |
Agenda
- Agenda review
- Review minutes of 2016-05-25_SGB_Conference_Call
- Homework
- Forward risks to the group for consideration
- Action Items
- Lorraine to send risk and precept material that Ron put together to the group
- Discussion Topics
- HTA Followup Discussion
- Risk assessment
- Defining the role of product director - joint with ARB
- Need to invite Grahame to discuss
- CDA Product Family Formation
- Further discussion on SGB Guidance on IG Conformance Statements (from 2016-02-22 TSC Call)
- Role of Steering Divisions
- FHIR Governance Board
- Balloting standards which are cross-product family
Minutes
Meeting Outcomes
Actions
|
Next Meeting/Preliminary Agenda Items |
© 2016 Health Level Seven® International. All rights reserved